CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU
Authors
Sabine Altrichter
Kemal Erol
+5 more
Ragıp Ertaş
Tomasz Hawro
Şule Ketenci Ertaş
Marcus Maurer
Kemal Özyurt
Publication date
1 January 2019
Publisher
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Institutional Repository of the Freie Universität Berlin
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:refubium.fu-berlin.de:fub1...
Last time updated on 30/08/2022
